Peptide PilotPeptide Pilot

Vial duration

MOTS-c vial duration calculator

Estimate how many weeks one 10 mg MOTS-c vial covers at your dose and weekly cadence.

Download Peptide PilotiPhone · Free to download

Total doses

2

Lasts

0.7 weeks

MOTS-c is a peptide encoded inside the mitochondria that people inject for metabolic effects — energy, insulin sensitivity, and exercise capacity. It signals to muscle and fat tissue to use glucose and fat more efficiently, essentially mimicking some effects of exercise at the cellular level. Animal studies show clear improvements in insulin sensitivity and endurance; human data is early. This page covers reconstitution math and a typical 2–3-times-per-week logging cadence.

How the MOTS-c vial duration calculator works

This calculator answers the inventory question: at your current dose and weekly cadence, how many weeks will this MOTS-c vial last? It is the math you need to plan refills before a vial runs dry mid-protocol — especially with peptides like GLP-1s where shipping windows can run several weeks.

The formula is two divisions. Total doses per vial equals vial mg divided by dose mg, rounded down. Weeks of supply equals total doses divided by doses per week. With a 10 mg vial of MOTS-c, a 5 mg dose, and 3 dose per week, the vial covers 2 doses, or about 0.7 weeks of supply.

The three inputs that move the answer: vial mg (set when you bought the vial), dose mg (set by your protocol step), and doses-per-week (set by the peptide's half-life). Once a vial is reconstituted it also has a stability ceiling — most lyophilized peptides reconstituted in BAC water are typically used within four to six weeks of refrigerated storage, so a vial that mathematically lasts twelve weeks may not last twelve weeks in practice.

Use this calculator before opening a new vial to confirm the dose and cadence you have planned will not strand you halfway through. Use it again whenever you titrate up — a dose increase shortens vial life, sometimes dramatically. The calculator is intentionally conservative: it floors total doses, never assumes partial-dose draws, and never extends weeks beyond what whole doses support.

MOTS-c cadence and how it changes vial life

Published research and user-documented protocols frequently describe an administration schedule of three times per week or on an every-other-day basis. This cadence is notably different from daily or weekly routines, introducing a significant variable for tracking adherence. The administration itself is typically documented as a subcutaneous injection, using a standard U-100 insulin syringe for measurement and delivery. Due to the relatively large dose size often studied, the choice of final concentration after reconstitution becomes an important practical consideration.

The timing of administration is another variable that individuals may choose to document in a personal log. Some experimental designs have explored the administration of MOTS-c in relation to physical activity, with the goal of studying its influence on exercise-induced metabolic adaptations. Others have examined its effects relative to fasting or fed states. Consequently, a detailed personal log might record not only the dose and date but also the time of day and its proximity to meals or exercise sessions to observe any patterns over time.

Published research protocols often use specific, fixed administration schedules, such as every-other-day dosing, to create a controlled environment. The goal in a formal study is to standardize all inputs to accurately observe the effects of a single variable. In contrast, a personal tracking plan documented on a platform serves the purpose of individual record-keeping and auditing. Users can plan and log their own schedule, which may be structured to mirror a research protocol or adjusted based on personal documentation goals.

Storage and shelf life for MOTS-c

Before it is mixed with a diluent, the lyophilized powder form of MOTS-c is maintained in refrigerated conditions to preserve its structure. Once reconstituted with bacteriostatic water, the vial containing the solution should also be stored in a refrigerator. Users typically plan to expend the contents of the reconstituted vial over a planned duration, often documented as a period of several weeks, to align with their protocol's schedule.

Tracking MOTS-c vials in a real log

The every-other-day or three-times-per-week cadence associated with MOTS-c presents a distinct tracking challenge compared to simpler schedules. This irregular pattern is uniquely susceptible to unintentional drift, where the intended frequency is not maintained over time. To counteract this, a meticulous log is essential for documenting the exact date and time of each administration. Such a detailed record is the only reliable method for retrospectively auditing the actual dosing schedule and observing its consistency, which is a primary goal of personal protocol tracking.

For a detailed personal log, one can track more than just the administration schedule. Given the research focus on energy homeostasis, individuals could document exercise-related metrics like endurance performance or perceived exertion levels. Other relevant data points to monitor might include body composition figures or subjective scores for daily energy. Documenting these variables alongside a MOTS-c schedule allows for a more comprehensive personal audit, revealing patterns that may be of interest for future review.

Common MOTS-c vial-planning mistakes

  • Failing to maintain a strict calendar-based log, leading to the every-other-day schedule drifting into an inconsistent and untrackable pattern.
  • Calculating a unit dose based on a generic concentration instead of the specific concentration derived from their vial size and chosen diluent volume.
  • Reconstituting a 10 mg vial with 2 mL of water and being unprepared for the large 1 mL (100 unit) injection volume required for a 5 mg dose.
  • Confusing MOTS-c's classification as a mitochondrial-derived peptide with unsupported claims about its direct effects on mitochondrial populations.
  • Assuming the administration timing relative to meals or exercise is irrelevant without systematically tracking it as a variable in a personal log.
  • Confusing its studied mechanism with other metabolic peptides, overlooking that its mitochondrial origin represents a distinct signaling pathway.
  • Committing calculation errors when converting between milligrams and micrograms, a frequent issue due to its higher milligram-level doses.
  • Failing to consistently document the administration cadence (e.g., every other day), a key variable studied for its effect on signaling pathways.

Frequently asked questions about MOTS-c vial duration

What specifically makes MOTS-c different from other peptides tracked on this site?
MOTS-c is unique because it is a mitochondrial-derived peptide (MDP). This means its genetic code originates from DNA within the mitochondria, not the cell's nucleus. All other peptides in this catalog are either encoded by the nuclear genome or are fully synthetic analogs, making MOTS-c's biological origin fundamentally distinct.
How do I use the calculator to find how many units to draw for a 5 mg dose?
First, you must establish the concentration. If you reconstitute a 10 mg vial with 2 mL of bacteriostatic water, the concentration is 5 mg per mL. Since a U-100 insulin syringe holds 1 mL total, a 5 mg dose requires a full 1 mL of this solution, which equals 100 units on the syringe.
Why is it so important to log every MOTS-c administration date?
The common three-times-per-week or every-other-day schedule lacks the simple repetition of daily or weekly protocols. This irregularity makes it very easy for the schedule to drift over time. A precise log with dates ensures you have an accurate record of the actual frequency, which is necessary to review the consistency of your self-directed protocol.
What is the significance of the AMPK pathway in relation to MOTS-c?
The AMP-activated protein kinase (AMPK) pathway is a primary cellular energy sensor. Much of the scientific research on MOTS-c has studied its ability to influence this pathway. This interaction is the proposed mechanism through which MOTS-c exerts effects on metabolism, and it provides the scientific framework for its investigation in studies of metabolic regulation.
Can I reconstitute the 10 mg vial with a different volume of water, like 1 mL?
Yes, the diluent volume can be adjusted, but it changes the dose calculation. Using 1 mL of water in a 10 mg vial would create a 10 mg/mL solution. A 5 mg dose would then require only 0.5 mL (50 units), which may be a more comfortable injection volume for some individuals. It is critical to use the calculator to convert your desired dose based on your actual concentration.
Was MOTS-c invented in a lab or discovered in nature?
MOTS-c was discovered. A research team at the University of Southern California identified it in 2015 as a naturally occurring peptide produced within mitochondria. It is therefore classified as an endogenous signaling molecule, not a synthetic compound that was invented or designed in a laboratory.
What is the research origin of MOTS-c?
MOTS-c was first described in a 2015 *Cell Metabolism* paper by researchers at the University of Southern California. Its unique characteristic is its origin from the mitochondrial genome, specifically from a small open reading frame in the 12S rRNA gene. This classifies it as a mitochondrial-derived peptide (MDP), distinguishing it from peptides encoded by nuclear DNA.
Why do some study protocols for MOTS-c specify an every-other-day cadence?
The every-other-day or three-times-per-week cadence observed in certain research is planned in relation to the peptide's studied properties. MOTS-c is documented to have a relatively short half-life. An intermittent schedule allows researchers to observe the effects of pulsing or cyclically activating cellular pathways, such as the AMPK pathway, rather than inducing a state of constant saturation that might occur with daily administration.
What does the 'MOTS-c' acronym represent?
The acronym MOTS-c stands for 'Mitochondrial Open reading frame of the Twelve S rRNA-c'. This name is a direct description of its genetic location. It is derived from a small open reading frame (ORF) on the 12S ribosomal RNA (rRNA) gene, which is located in the mitochondrial DNA.

Related on Peptide Pilot

Track MOTS-c vials automatically

Download on the App Store
Get the App